Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

HOPE Social Media Intervention for HIV Testing and Studying Social Networks

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02944877
Recruitment Status : Active, not recruiting
First Posted : October 26, 2016
Last Update Posted : February 4, 2021
Sponsor:
Collaborator:
University of California, Los Angeles
Information provided by (Responsible Party):
Sean D Young, University of California, Irvine

Brief Summary:
This study [HOPE: Harnessing Online Peer Education] seeks to determine the efficacy of using online social networks to scale peer community leader models to increase HIV prevention within African-American and Latino men who have sex with men. The peer community leader model, which teaches community popular opinion leaders about how to disseminate behavior changes messages throughout the community, has been proven to increase HIV prevention behaviors. Social media and online communities, such as Facebook, may be a cost-effective platform for scaling these models. Primarily upper middle-class White populations used the Internet in its early years, however, Internet use within African-American and Latino households has recently increased dramatically, especially on social media. People using the Internet may be at the highest risk for contracting HIV and are using novel Internet approaches to find sex partners, such as through social media. This is the first study to examine the effectiveness of the HOPE social media intervention to increase HIV testing among at-risk groups in the United States.

Condition or disease Intervention/treatment Phase
HIV Behavioral: social media intervention Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 900 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: HOPE Social Media Intervention for HIV Testing and Studying Social Networks
Actual Study Start Date : December 2016
Actual Primary Completion Date : January 31, 2021
Estimated Study Completion Date : December 31, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

Arm Intervention/treatment
Experimental: intervention
experimental
Behavioral: social media intervention
social media intervention

control
Other
Behavioral: social media intervention
social media intervention




Primary Outcome Measures :
  1. Number of participants requesting HIV Self-Testing [ Time Frame: 5 years ]
    At home/self HIV testing kits will be provided to all participants.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 89 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Male
  • Sexually active with another man in the last 12 months
  • Willing and capable of understanding and assenting to an online informed consent form
  • Has (or willing to create) a social media page.

Exclusion Criteria:

  • Does not satisfy inclusion criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02944877


Locations
Layout table for location information
United States, California
University of California Irvine
Irvine, California, United States, 92697
Sponsors and Collaborators
University of California, Irvine
University of California, Los Angeles
Investigators
Layout table for investigator information
Principal Investigator: Sean Young University of California, Irvine
Layout table for additonal information
Responsible Party: Sean D Young, Associate Professor of Emergency Medicine and Informatics, University of California, Irvine
ClinicalTrials.gov Identifier: NCT02944877    
Other Study ID Numbers: 1R01MH106415 [HS# 2020-5768]
1R01MH106415 ( U.S. NIH Grant/Contract )
First Posted: October 26, 2016    Key Record Dates
Last Update Posted: February 4, 2021
Last Verified: February 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No